Triage >75% of chest pain patients in 1 hour.
In the case of suspected AMI, prompt treatment is essential. Every 30 minutes of delay between symptoms and treatment increases the 1-year mortality rate by 7.5%.
Troponin is the preferred biomarker in defining AMI according to the European Society of Cardiology (ESC) guidelines.8 In addition, it is the gold standard to distinguish between AMI and non-AMI patients.
Elecsys® Troponin T-high sensitive (TnT-hs) can reduce the time needed to rule-in or rule-out NSTEMI to as little as just 1 hour.
Supporting early and confident diagnosis with Elecsys® Troponin T-high sensitve
As supported by the use of the 0/1 hour rule-in and rule-out algorithm recommended by international guidelines.
Safely reduce time to diagnosis
▸ Triage over 75% of patients within 1 hour as validated by three multicenter studies with over 3,000 patients1
▸ Safely rule-out AMI and confidently discharge patients based on a high negative predictive value (99.1% – 100%) and low 30 day mortality rate (0.0% – 0.2%)
Lower the need for cardiac stress testing
▸ Significantly reduce the need for cardiac stress testing by exercise electrocardiogram (ECG)
Shorten stays in the emergency department (ED)
▸ Facilitate early discharge or transfer from the ED by reducing time spent in ED by 2.1 hours (33%) vs standard practice
Assay time – 9 minute STAT assay
